Literature DB >> 23392602

[Fcγ receptors].

J E Gessner1, R E Schmidt.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23392602     DOI： 10.1007/s00393-012-1006-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  14 in total

1.  STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation.

Authors:  Attila Braun; J Engelbert Gessner; David Varga-Szabo; Shahzad N Syed; Stephanie Konrad; David Stegner; Timo Vögtle; Reinhold E Schmidt; Bernhard Nieswandt
Journal:  Blood       Date:  2008-10-21       Impact factor: 22.113

2.  Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.

Authors:  Guillaume Cartron; Laurent Dacheux; Gilles Salles; Philippe Solal-Celigny; Pierre Bardos; Philippe Colombat; Hervé Watier
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

Authors:  Nelli Shushakova; Julia Skokowa; Jurriaan Schulman; Ulrich Baumann; Jörg Zwirner; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

4.  Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab.

Authors:  A Ruyssen-Witrand; S Rouanet; B Combe; M Dougados; X Le Loët; J Sibilia; J Tebib; X Mariette; A Constantin
Journal:  Ann Rheum Dis       Date:  2012-02-25       Impact factor: 19.103

Review 5.  FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.

Authors:  Heather A Niederer; Menna R Clatworthy; Lisa C Willcocks; Kenneth G C Smith
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

6.  Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis.

Authors:  Heinfried H Radeke; Iska Janssen-Graalfs; Eveline N Sowa; Nelli Chouchakova; Julia Skokowa; Fabian Löscher; Reinhold E Schmidt; Peter Heeringa; J Engelbert Gessner
Journal:  J Biol Chem       Date:  2002-04-30       Impact factor: 5.157

7.  Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice.

Authors:  Varsha Kumar; Syed R Ali; Stephanie Konrad; Jörg Zwirner; J Sjef Verbeek; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

8.  Arthritis critically dependent on innate immune system players.

Authors:  Hong Ji; Koichiro Ohmura; Umar Mahmood; David M Lee; Frans M A Hofhuis; Susan A Boackle; Kazue Takahashi; V Michael Holers; Mark Walport; Craig Gerard; Alan Ezekowitz; Michael C Carroll; Michael Brenner; Ralph Weissleder; J Sjef Verbeek; Veronique Duchatelle; Claude Degott; Christophe Benoist; Diane Mathis
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

9.  Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb.

Authors:  Sofia E Magnusson; Maria Andrén; Kajsa E Nilsson; Peter Sondermann; Uwe Jacob; Sandra Kleinau
Journal:  Clin Immunol       Date:  2008-03-17       Impact factor: 3.969

10.  Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).

Authors:  S Werwitzke; D Trick; P Sondermann; K Kamino; B Schlegelberger; K Kniesch; A Tiede; U Jacob; R E Schmidt; T Witte
Journal:  Ann Rheum Dis       Date:  2007-06-08       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.